Elite Pharmaceuticals (ELTP) EBIT (2010 - 2026)
Elite Pharmaceuticals (ELTP) reported EBIT of $7.53 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 65.3% from $21.7 million a year earlier and down 26.1% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) EBIT (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Elite Pharmaceuticals' EBIT came in at $34.94 million, down 6.7% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $49.11 million, up 150.6% from FY2025.
- EBIT has increased for three consecutive fiscal years, with a five-year compound annual growth rate of 87.8% (FY2021 to FY2026).
- By fiscal year, EBIT came in at $19.6 million in FY2025 (+81.7%), $10.79 million in FY2024 (+193.5%), $3.68 million in FY2023 (-27.5%) and $5.07 million in FY2022 (+140.9%).
- The fiscal Q1 2027 figure ranks as the lowest quarterly EBIT since fiscal Q3 2025.
- Year over year, EBIT gained in five of the last eight quarters, with growth averaging 181.9%.
- The high point for year-over-year EBIT in five years was fiscal Q3 2026 (growth of 721.0%); the low point was fiscal Q3 2025 (a decline of 68.9%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $10.19 million (Q4 2026), $9.01 million (Q3 2026) and $8.21 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Elite Pharmaceuticals | 258.43 Mn | 140.10 Mn | 13.51 Mn | 7.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.53 Mn |
| Mar 31, 2026 | 10.19 Mn |
| Dec 31, 2025 | 9.01 Mn |
| Sep 30, 2025 | 8.21 Mn |
| Jun 30, 2025 | 21.70 Mn |
| Mar 31, 2025 | 11.15 Mn |
| Dec 31, 2024 | 1.10 Mn |
| Sep 30, 2024 | 3.48 Mn |
| Jun 30, 2024 | 3.86 Mn |
| Mar 31, 2024 | 3.73 Mn |
| Dec 31, 2023 | 3.53 Mn |
| Sep 30, 2023 | 1.93 Mn |
| Jun 30, 2023 | 1.60 Mn |
| Mar 31, 2023 | -386,899.00 |
| Dec 31, 2022 | 1.96 Mn |
| Sep 30, 2022 | 1.08 Mn |
| Jun 30, 2022 | 1.02 Mn |
| Mar 31, 2022 | 851,676.00 |
| Dec 31, 2021 | 1.83 Mn |
| Sep 30, 2021 | 1.42 Mn |
API Access
Elite Pharmaceuticals EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();